CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 9.79: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.79%Below 5Y avg (0.99%)
Annual Rate
CNY 0.05Paid annual
Payout Ratio
43.0%Sustainable
Last Ex-Dividend
May 26, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.01BCNY299.70M · vs all stocks (USD)
Trailing P/E
32.35xRevenue (TTM)
407.10MCNY60.79M · vs all stocks (USD)
Profit Margin
14.63%Beta
0.2540xvs all stocks
52-Week Change
-10.17%vs all stocks
Market Capitalization
2.01BCNY299.70M · vs all stocks (USD)
Enterprise Value
1.71BCNY254.64M · vs all stocks (USD)
Trailing P/E
32.35xPrice to Sales (TTM)
4.75xPrice to Book (MRQ)
1.99xEnterprise to Revenue
4.19xEnterprise to EBITDA
17.32xGross Margin
33.51%Profit Margin
14.63%Operating Margin
12.13%Return on Assets (TTM)
2.96%Return on Equity (TTM)
6.13%Revenue (TTM)
407.10MCNY60.79M · vs all stocks (USD)
Revenue per Share (TTM)
1.37CNYUpdated Sep 21, 2026Quarterly Revenue Growth
-24.10%Gross Profit (TTM)
127.08MCNY18.98M · vs all stocks (USD)
EBITDA (TTM)
74.55MCNY11.13M · vs all stocks (USD)
Net Income (TTM)
59.57MCNY8.90M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-23.60%Operating Cash Flow (TTM)
123.38MCNY18.42M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
110.30MCNY16.47M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0530CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
0.79%vs all stocks
5-Year Average Dividend Yield
0.99%vs all stocks
Payout Ratio
43.00%Minority Interest (Equity)
1.42MCNYFY2025 · Dec 31, 2025Revenue
460.42MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
323.47MCNYFY2025 · Dec 31, 2025Gross Profit
136.96MCNYFY2025 · Dec 31, 2025Operating Income
65.67MCNY9.81M · vs all stocks (USD)
Pre-tax Income
74.44MCNYFY2025 · Dec 31, 2025Income Tax Expense
9.33MCNYFY2025 · Dec 31, 2025Net Income
65.11MCNYFY2025 · Dec 31, 2025EBIT
74.45MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
124.85MCNYFY2025 · Dec 31, 2025Research & Development
12.65MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
27.87MCNYFY2025 · Dec 31, 2025Other Operating Expenses
4.41MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
12.40MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
13.28KCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
65.11MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-126.61KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
61.68MCNYFY2025 · Dec 31, 2025Free Cash Flow
57.82MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
80.02MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
65.11MCNYFY2025 · Dec 31, 2025Other Non-cash Items
-10.17MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-15.64MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
22.38MCNYFY2025 · Dec 31, 2025Capital Expenditures
-3.86MCNYFY2025 · Dec 31, 2025Sale of Investments
22.54MCNYFY2025 · Dec 31, 2025Other Investing Activity
-87.49MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-68.81MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-29.31MCNYFY2025 · Dec 31, 2025Other Financing Charges
-656.36KCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-29.97MCNYFY2025 · Dec 31, 2025Shares Outstanding
299.10MSharesUpdated Sep 21, 2026Float Shares
173.65MSharesUpdated Sep 21, 2026% Held by Insiders
45.98%vs all stocks
% Held by Institutions
4.41%vs all stocks
Total Cash (MRQ)
230.65MCNY34.44M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.7710CNYUpdated Sep 21, 2026Total Debt (MRQ)
0.00CNYvs all stocks (USD)
Total Debt to Equity (MRQ)
0.00xCurrent Ratio (MRQ)
3.40xBook Value per Share (MRQ)
3.26CNYUpdated Sep 21, 2026Total Assets
1.11BCNY165.44M · vs all stocks (USD)
Total Current Assets
399.79MCNYFY2025 · Dec 31, 2025Total Liabilities
146.37MCNYFY2025 · Dec 31, 2025Total Non-current Assets
708.10MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
15.19MCNYFY2025 · Dec 31, 2025Total Current Liabilities
131.18MCNYFY2025 · Dec 31, 2025Cash
155.47MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
155.47MCNYFY2025 · Dec 31, 2025Accounts Receivable
126.87MCNYFY2025 · Dec 31, 2025Inventory
75.76MCNYFY2025 · Dec 31, 2025Accounts Payable
91.26MCNYFY2025 · Dec 31, 2025Short-term Debt
21.61KCNYFY2025 · Dec 31, 2025Other Current Liabilities
105.22KCNYFY2025 · Dec 31, 2025Common Stock (Book)
299.10MCNYFY2025 · Dec 31, 2025Retained Earnings
500.10MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
961.52MCNY143.58M · vs all stocks (USD)
52-Week Low
5.53CNYUpdated Sep 21, 202652-Week High
8.62CNYUpdated Sep 21, 202652-Week Change
-10.17%vs all stocks
Beta
0.2540xvs all stocks
50-Day MA
6.41CNYUpdated Sep 21, 2026200-Day MA
7.35CNYUpdated Sep 21, 2026Avg 10-Day Volume
4.14MSharesUpdated Sep 21, 2026Avg 30-Day Volume
4.66MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.2000CNYUpdated Sep 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 9.79: safe zoneNotable
Altman Z-Score: 9.79
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Shanghai Hile Bio-Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sab Biotherapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
X4 Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
JBM
Tier 1ProductionApproval-Gated PipelineRuleFlow
Century Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hikal Ltd.
Tier 1ProductionApproval-Gated PipelineRule
EyePoint Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Essex Bio-Technology Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Lavipharm S.A.
Tier 1ProductionApproval-Gated PipelineRuleFlow
AtaiBeckley Inc.
Tier 1ProductionApproval-Gated PipelineRule